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Summary
A common goal of microarray experiment is to identify genes that are differentially
expressed under different biological conditions. In this thesis, we studied a time-
course microarray gene expressions under the action of CYC202 on 3 cell lines. The
intended aim is to investigate the time-course regulation and differential expression
in relation to the responses. However, it is challenging to analyze this dataset. The
difficulties arise mainly from at least two aspects: no repeated measurements, and
a small number of time point measurements. We set out more modest objectives
in our work: to explore the different aspects of this dataset, to possibly uncover
the salient features of the dataset; and hopefully to shed light on how the genes
respond to the action of CYC202.
Statistical methods we have attempted include (i) good hierarchical clustering
based on appropriate choice of distance measure to explore which sets of genes
respond similarly or differently in relation to different cell lines; (ii) principal com-
ponent analysis for dimension reduction to understand and visualize the dataset,
and perhaps to discover which time point(s) are more informative; (iii) association
vii
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study of coregulation and reverse-regulation using the time-course patterns and
profile analysis.
Though these methods do not succeed to give concordant results, in each statis-
tical method some subsets of genes were identified to behave differently from the
majority of the genes. Constrained by our knowledge in molecular biology, we
cannot assess whether these genes are really of biological importance. This under-
lines the need for close collaboration with the biologists to unearth the biological
information in this interesting and challenging dataset.
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Chapter 1
Introduction
Increasing availability of high-throughput and multiplex techniques for quantify-
ing signaling and cellular responses make it immediately feasible to collect large
datasets on gene expression and activity. Moreover, features of biological activi-
ties are hidden into those large data sets and it is really very hard to picture out
them only by inspection. But, the aim is to extract the understanding of signal-
transduction networks and complex biological meaning. This leads to modeling
the data-driven structure to explore the biological activities of genes.
The study of cell signaling entails measuring the levels, localization and activities
of several proteins over a range of timescales and treatment conditions. There-
fore, data organization by using the clustering and dimension reduction techniques
play a key role to investigate the biological insight of the genes. For the target
specific biological system monitoring both supervised and unsupervised process
serve as pioneer to biological signal tracking. Similarly, both the homogenous and
heterogeneous expression patterns can bear meaningful biological systems and reg-
ulations. Cellular signals are not static but dynamic and time courses are perhaps
1
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the most fundamental type of signaling data set. In static gene expression experi-
ments, a snapshot of gene expression levels is taken where as a temporal process is
measured in case of dynamic experiments. Consequently, the tracking of disease-
specific markers and the treatment outcomes depend on this temporal process. In
the next subsequent sections, we would carry out an extensive discussion on this
issue, especially the dynamics of genetic interaction networks and prediction of
drug-path.
1.1 Data processing
In our study, we have used the NPC gene expression dataset that consists of 380
genes to investigate the drug response and drug target tracking. Each gene has six
unreplicated expression levels corresponding to six time points. The dataset comes
from an in vitro experiment on three different cell lines namely CNE1, CNE2,
and HK1. In fact, a cyclin dependent kinase (CDK) inhibitor, CYC202, was used
to study its anti-tumor activities in human Nasopharyngeal Carcinoma (NPC)
cells. The gene expression level of three cell lines CNE1, CNE2, and HK1 were
measured before the treatment of CYC202, and after 2, 4, 6, 12, and 24 hours of the
treatment. Among the three cell lines CNE1 responded poorly, CNE2 responded
in a limited way, and HK1 fully responded to the treatment (Soh et al., 2007).
The number of time points under study is six but are not equally spaced in hours
(0h, 2h, 4h, 6h, 12h and 24h). Consequently, for CNE1 microarrays for all genes
corresponding to time point 0h is unity. So, there are five working microarrays
for each gene in CNE1 as there is no replication. Although the experiment was
conducted over 380 genes, many of them do not express and seem to be missing.
Thus after excluding these unexpressed genes we have 275 genes and each gene
having five microarrays in CNE1 and six microarrays in CNE2 and HK1.
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Many biological systems are dynamic. Gene expression levels change over time
and over the course of biological process. Once the genes have been clustered in
different sets, the notion of classification may be the dynamic effect among gene
sets. Evidently, time-lagged coregulation between (or among) gene sets become a
vital issue as activation of one set of genes may activate or inhibit other gene sets
after some time period. Ji and Tan (2005) developed a procedure for identifying
coregulated patterns. However, not all the observed coregulated patterns are im-
portant or biologically interesting. Besides, some genes may be highly expressed
whereas some may express in a very limited way or even may not express in some
particular time points. Highly expressed genes are assumed to be more active in
a biological process than lower expressed genes. Thus variation of expression level
between two time points is also important. Therefore, we aim to select a set of
coregulated patterns based on the procedures of Ji and Tan (2005) but with a good
choice of change of expression level between two time points.
Analysis of gene expression data can identify regulatory relationships between
genes. Whilst, clustering techniques are applied to identify the coexpressed genes,
and association rule in data mining has been used to detect gene regulation across
numerous path-ways, these methods usually consider gene expression levels under
the same conditions or at the same time points, and they do not consider any
time-lagged relationships (Ji and Tan, 2005). Consequently, for time series data
time-lagged relationship (or dynamic interaction) may be observed. Thus, for time
series gene expression data it is apparent that sets of genes may or may not reg-
ulate each other at the same time point. In fact, such gene regulation may occur
after a certain time lag. In other words, the products that a gene produces during
the expression process may affect other gene(s) expression later, that is, activation
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of one gene may activate or inhibit another gene after some time periods. Thus
there exhibits four kind of regulatory relationships namely activation, inhibition,
non-activates, and non-inhibits (Soh et al., 2007). So, it is possible to construct a
time-lagged regulatory path-ways among the gene sets.
In microarrays, sometimes there are thousands of genes with time-lagged expres-
sion. Due to a large number of genes and the complexity of biological processes,
clustering of genes is one of the most commonly used statistical methods for ana-
lyzing such data. Clustering genes with similar expression profiles can potentially
be utilized to predict the functions of gene products with unknown functions,
and to identify sets of genes that are regulated by the same mechanism (Luan
and Li, 2003). Both model-based and non-model based clustering methods are
available. Moreover, the hierarchial clustering (Eisen et al, 1998), self-organizing
maps (Tamayo et al, 1999), and the graph-based CAST algorithm (Ben-Dor and
Yakhini, 1999) are very popular. Consequently, clustering method based on multi-
variate normal mixture model where each gene is assumed to come from a mixture
of multivariate normal densities with different means and certain parameteriza-
tions of the covariance matrix (Fraley and Raftery, 2003), have also been used to
cluster genes based on their expression profiles over time or over different samples
(Yeung et al., 2001).
Model-based clustering has become popular over the last few years. Luan and
Li (2003) developed the mixed-effects model for the time-course gene expression
data using B-splines (De Boor, 1978) assuming gene expression level as a contin-
uous function of time. The same model was also developed by Bar-Joseph et al.
(2003a) but using a cubic B-spline and EM algorithm. Apart from this, Luan and
Li (2003) employed the EM algorithm under the mixed-effects model and also used
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the Bayesian inference criteria (BIC) to determine the number of clusters in the
dataset. Sometimes discovering the local structure of expression might have some
notion of biological insight. Motivated by the data-driven structures Nguyen and
Rocke (2002) used partial least squares (PLS) to classify the tumor genes from
a microarray experiment. Very recently, Martella et al. (2008) presented an ex-
tension of the mixture of factor analyzers model (MFA) allowing for simultaneous
clustering of genes and conditions. Since consideration of the temporal effect dur-
ing classification is very important and Ma et al. (2006) proposed the smoothing
spline clustering (SSCLUST). Another pioneer model based clustering procedure,
MCLUST, that is based on the variance structure of data and mixture models
(Fraley and Raftery, 2003 and 2006) also become popular in recent years. How-
ever, none can prove the superiority of a particular method. Most of the methods
have their advantages in some particular situations. Very recent study by Gersh-
man (2008) shows the superiority of model based MCLUST over the model based
SSCLUST and non-model based K-means clustering when the variance between
the clusters are large. Consequently, he shows that when the variance between the
clusters are small then the model based SSCLUST outperform the MCLUST. For
short time-course microarrays Ernst and Bar-Joseph (2006) proposed a method
that is suitable both for time-course profile analysis as well as for GO category
enrichment.
Genes may be classified into hundreds or thousand of groups. However, it is sub-
ject to investigate whether gene sets are significant or not. Gene set enrichment
analysis (GSEA) procedure (Subramanian et al., 2005) is a microarray data analy-
sis method that uses predefined gene sets and ranks of genes to identify significant
biological changes in microarray datasets. Kim and Volsky (2005) developed the
parametric analysis of gene set enrichment (PAGE). Efron and Tibshirani (2007)
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proposed two main improvements in GSEA, the use of maxmean statistic for sum-
marizing gene-sets, and restandardization for more accurate inferences. Naturally,
some sets of gene expressions are correlated and so Jiang and Gentleman (2007)
used principal component analysis (PCA) to identify the gene sets with correlated
expression. Although many procedures have been proposed by many authors,
however, considering the temporal effect is very important for time-course gene
expression profiles. Motivated by this, Bar-Joseph et al. (2003b) introduced the
continuous representation of time-course gene expression and proposed the B-spline
based GSEA in which the control polygon plays a vital role to compute the asso-
ciated probability. However, their method requires repeated measurement of gene
expression. Even with the repeated microarrays their method can compare only
two curves from two different biological conditions or cell lines at a time. Storey
et al. (2005) and Leek et al. (2006) developed EDGE method that enables to find
differentially expressed genes by comparing several biological conditions. However,
this method uses more than one individuals to fit longitudinal models. Recently,
DeCook et al. (2006) developed a procedure for finding differential expression in
case of unreplicated time-course microarrays.
The large amount of data acquired from DNA microarrays can be reduced to a
smaller set of genes to represent meaningful biological differences between control
and test systems and validated in an experimental or clinical setting (Kim and
Volsky, 2005). However, to study the drug effect on a large volume of genes some
interaction features may be observed such as coregulation, activation, and inhi-
bition. This is somewhat challenging to find a suitable method for investigating
such relationship especially when the experiment is conducted on a very few time
points without any repeat. Even if it is possible to find a suitable model the next
challenge is to match the statistical relationship with the biological meaning. Thus
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profile analysis of gene expression level by classification and matching this with the
biological meaning would be beneficial to explore the gene regulatory relationship.
Our dataset comes from an in vitro experiment and contains only six microarrays
corresponding to six time points from each cell line. Thus for the analysis of our
dataset we would apply some of the methods discussed above and those are most
suitable with respect to our data.
1.3 Previous works
Nasopharyngeal carcinoma (NPC) is a cancer with a striking geographical and
ethnic distribution. High frequency of this cancer is observed among the Southern
Chinese but is rare elsewhere in the world. Infection with a ubiquitous herpesvirus,
Epstein-Barr virus (EBV), genetic predisposition, and dietary and environmental
factors are believed to contribute to its development. Continuous effort is going
on by many researchers and research institutes to elucidate the molecular genetics
of this cancer and discovering biomarkers that may be useful in diagnosis of this
cancer, deciphering how the EBV viral oncoprotein interacts with cellular signal-
ing mechanisms to induce cancer, and developing novel immunotherapeutic and
photodynamic therapy approaches for its treatment. However, most of the gene
expression profiling with microarrays were emphasizing the development of NPC
and detecting genes related to the tumor suppression (Lung et al., 2006). Soh
et al. (2007) studied the network enrichment analysis aiming to investigate the
change of regulatory patterns between regulator and regulatees. This enables us
to hypothesize whether the pathway is behaving normally or not. However, there
are many issues regarding time-course expression of genes during hypothesis gen-
eration as well as finding differential expression. Deciphering pathways have been
studied by many authors, for examples, H-Ras pathway by Gaffre et al. (2006)
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and apoptotic pathway by Lincz (1998). Apart from this, we can monitor the drug
response pathways to conduct the study on target genes and the dynamic inter-
action among genes to apoptosis, cell cycle, and mitogen-activated protein kinase
(MAPK) pathways. Our aim in this study is to explore the expression change of
some genes on such pathways and to hypothesize some genes which are significantly
responding to the CDK inhibitor.
1.4 Objectives of the study
This study is going to be challenging statistically as there are only few time-course
expression levels for each gene coupled with the fact that there is no replication.
This setting is in stark contrast from usual statistical framework where sample
size (number of replications) is reasonably large. We shall therefore focus on the
explorations of this interesting dataset to hopefully unearth some salient features
of this dataset with some principled statistical methodologies. Objectives of this
study are:
(1) Examine this dataset with a variety of statistical procedures to discover any
salient features of gene expression in this dataset; and
(2) Hypothesize some influential gene expression in relation to drug response for
further collaboration/examination by the biologists.
1.5 Organization of the thesis
To reach the goal of our objectives, we have divided the whole thesis into five
chapters. In Chapter 2, as part of data organization genes are classified into dif-
ferent classes based on some suitable methods such as hierarchical clustering and
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principal component analysis (PCA) to identify genes of unusual time-course gene
expressions. In Chapter 3, time-lagged relationship such as time-course coregu-
lation, activation and inhibition of gene expression profiles are studied. Here we
propose a cardinality based optimal threshold selection procedure to classify genes
in different patterns. Moreover, this threshold value has been used to study the
time-course regulation property of the genes. In Chapter 4, gene set enrichment
analysis has been carried out to identify differentially expressed genes. Lastly,
Chapter 5 is devoted to results and discussions. Here we organize results of our
statistical analysis with possible biological interpretation.
1.6 Software
All of the techniques described in this thesis were implemented using R version
2.6.2, an open-source implementation of the S programming language (R Develop-
ment Core Team, 2007). A JAVA based tool, STEM, that is used for gene ontology
category enrichment analysis is available at http://www.cs.cmu.edu/ jernst/stem/.





Data organization is a very important procedure that enables us to split a large
dataset into some meaningful subsets of objects. Thus analyzing the subsets of
objects one can extract the inner feature of objects and their correlates. Gene
expression data contains many genes and so clustering techniques become very
useful to search similar gene expression patterns. Sometimes unusual expression
patterns also bear some special biological interest. In this regards, dimension
reduction by principal component analysis (PCA) and outlier detection are popular
tools to dig out some biological interest into the data space. In the next subsequent
sections, we would apply these methods to a time-course nasopharyngeal carcinoma
gene expression dataset to find both similar and unusual gene expressions.
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2.2 Hierarchical clustering
2.2.1 Distance measures
Hierarchical cluster analysis depends on the type of distance measure used. Let
X = (x1, x2, . . . , xd)
T and Y = (y1, y2, . . . , yd)
T be two column vectors then some
distance measures used in agglomerative clustering are given below:
(1) Maximum: dmax(X, Y ) = max1≤i≤d |xi − yi|
(2) Manhattan: dman(X,Y ) =
∑d










|xi + yi| =

|xi−yi|
|xi+yi| if xi 6= −yi
0 if xi = −yi or xi = −yi





(4) Minkowski: dmink(X,Y ) =
[∑d
i=1 |xi − yi|p
]1/p
(5) Euclidean: deuc(X,Y ) =
√∑d
i=1 (xi − yi)2
(6) Correlation: dcor(X,Y ) =
1−rX,Y
2
where rX,Y is the correlation coefficient be-
tween X and Y . Three types of correlations used to compute the correlation
coefficients are Pearson correlation (rX,Y ), Spearman rank correlation (ρX,Y )
and Kendall’s tau (τX,Y ) coefficient.
2.2 Hierarchical clustering 12
2.2.2 K means clustering








(xil − xjl)2 (2.1)
for a matrix X of order N × d with N objects as rows and desired number of
clusters K where xi and xj are ith and jth object respectively from kth cluster, Ck.
Algorithm:
(1) Make an initial guess the centers of the clusters. Use these initial values as
seeds and update by using steps (2) to (4).
(2) For each of the other data points, find the closest cluster based on distance
measure.
(3) Replace each cluster center by averaging data points those are closest to it.
(4) Repeat steps (2) and (3) until the assignments stop changing.
K-means may be very sensitive to the choice of centers in step (1) which are used
as seeds for the algorithm. The main problem is that the algorithm only converges
to a local minimum for the within-cluster sum of squares. Thus different runs with
randomly chosen centers can converge to different local minima.
2.2.3 Partitioning around medoids (PAM)
A medoid can be defined as that object of a cluster, whose average dissimilarity
to all the objects in the cluster is minimal. In the classification literature, such
representative objects are called centrotypes. Partitioning around medoids (PAM)
is applied in order to obtain the optimal number of clusters where the entries are
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grouped in a robust way (Kaufman and Rousseeuw, 1990, and Struyf et al., 1997).
It is a partitioning algorithm and can be regarded as a generalization of K-means
clustering to arbitrary dissimilarity matrices. This algorthm works in few steps
mentioned below:
(1) Randomly select K objects as medoids: m1,m2, . . . ,mK
(2) Assign each object to its closest medoid
(3) Compute the objective function






(4) Swap selected objects by unselected objects until no reduction of F
2.2.4 Silhouette width and number of clusters
The silhouette width is a measure of how many individual elements belong to the
cluster where they are assigned (Rousseeuw, 1987) and is used to select the best
number of clusters obtained with the PAM algorithm. To describe the overall
procedure we consider the case of classifying N objects in K clusters. Now, if an
object a belongs to the cluster Ck then the average dissimilarity between a and all
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Thus the dissimilarity between a ∈ Ck and the closest cluster that is different from








The status of classification for the object a can be examined by the following
criterion:
(1) well clustered if s(a) is near to 1
(2) may be in wrong cluster if s(a) < 0
(3) on the border between two clusters if s(a) is near to 0
To select the number of clusters to retain we use following steps:
(1) Apply PAM for K clusters Ck, k = 1, 2, . . . , K










(4) Number of clusters: K∗ = argmax{s¯K : 2 ≤ K ≤ N − 1}
In practice, one can run PAM several times, each times for different values of K
and then compare the resulting silhouette plots. The average silhouette width can
be used to select the best number of clusters, by choosing that K which yields the
highest silhouette width.
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2.2.5 Clustering NPC gene expression data
We would like to cluster NPC genes into different classes and would like to see
how these genes cluster together in different cell lines. To do this we use the cor-
relation distance measure based on Pearson correlation, Spearman correlation and
Kendall’s tau coefficients. We are interested in investigating the effect of different
correlation measures on clustering objects from dataset. Thus silhouette width is
computed by PAM algorithm for different number of clusters. As described in the
previous section, the optimal number of cluster is selected from the silhouette plot
such that the silhouette width is maximum.
We compute average silhouette width for cell line CNE1 and three different cor-
relation distance measures (Pearson, Spearman and Kendall). We plot average
silhouette width for different number of clusters starting from 2 to 50. We ob-
serve that the Pearson correlation distance serves fewer number of clusters (29)
with higher silhouette width (0.853) compared to other two correlation distance
measures (Figure 2.1). Also, in case of CNE2 we observe Pearson distance serves
better result than Spearman and Kendall’s distance measures (Figure 2.2). For
Pearson distance we get 27 clusters with 0.765 silhouette width. But for HK1 we
see that both the Pearson and Spearman correlation distance give nearly the same
silhouette width for 2 clusters (Figure 2.3). However, this result is maximum (sil-
houette width) for Pearson distance with 24 clusters. Since for only 2 clusters the
difference between silhouette width of Pearson and Spearman correlation measures
are very small it is very hard to decide any one. Consequently, with the increase
of number of clusters from 2 to 24 the improvement of silhouette width is very
low. Therefore, we need further investigation to explore the choice of a suitable
distance measure.
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Figure 2.1: Average silhouette width for CNE1

































Figure 2.2: Average silhouette width for CNE2
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Figure 2.3: Average silhouette width for HK1
Let us use the boxplot to view the data structure over different time points. From
Figure 2.4 it is depicted that the boxes in HK1 are smaller and those of CNE2
are larger among the three cell lines. In other words, the interquartile ranges
of microarrays corresponding to different time points in CNE2 are higher than
those of CNE1 and HK1. Moreover, microarrays corresponding to different time
points in CNE2 have more variances than those of CNE1 and those of CNE1 have
more variance than those of HK1. This depicts that the silhouette width may
be affected by the distance measure and variance structure of the dataset. In
our dataset, we explore that if the microarrays inflate the variance then Pearson
distance gives higher silhouette width with fewer number of clusters than Spearman
distance. On the other hand, if the interquartile range of microarrays is shorter
then the Spearman distance and Pearson distance provides nearly the same number
of clusters. But in all the cases Kendall’s tau coefficient based distance measure
performed clustering with lower level of precision.
Based on the number of clusters selected from the Pearson distance and silhouette
plot we construct dendograms to view the genes under different clusters. It is
2.2 Hierarchical clustering 18









Figure 2.4: Boxplot of CNE1, CNE2 and HK1
aparent that genes having similar expression patterns would be classified into a
same cluster. For cell line CNE1 we use 29 clusters and display them in Figure 2.5.
Dendograms obtained from CNE2 and HK1 are displayed in Figure 2.6 and Figure
2.7 with 27 and 24 clusters respectively. Now, if we compare the dendograms we
see that genes in different cell lines are grouped together in different ways. NFKB2
is grouped with many genes in the largest cluster of CNE1 (Figure 2.5) whereas in
CNE2 this is clustered with 8 other genes and that in HK1 with 28 other genes.
We observe that genes NFKB2 and HSPA4 are clustered together in CNE1 and
CNE2 but not in HK1. Besides, genes IFNA1, BAX, and UBE2N are clustered
individually in HK1 but not in CNE1 and CNE2 whereas SNF1LK is clustered
alone both in CNE2 and HK1. Gene MYC is clustered with few other genes in
CNE1 but clustered with FOSL1 and FOS in CNE2 and HK1 respectively. Thus
genes having similar expression in one cell line may have different kind of expression
in another cell line.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.2 Hierarchical clustering 22
Even though based on a principled method, silhouette width, clustering by the
Pearson distance does not unearth any significant patterns: the set of genes were
clustered very differently across these 3 cell lines. For example, the largest cluster
in HK1 consists of 71 genes. Closer examination did show that some of these 71
genes were found to co-express across all 3 cell lines. They are
{PRKACA, CDK4, BIRC2, XRCC5, MAP2K4, IKBKB, MAPK12, RAN },
{ RPS6KB1, MAP2K1, RRM2, PCNA, DCTD }, and
{E2F1, MAPK14, AKAP9, RRM1}.
Furthermore, these subsets of genes are clustered together in each cell line. On the
other hand, many of these 71 genes were not clustered together in CNE1. These
are
A={ 18S, ARRB2, B2M, BID, BTRC, CASP6, CCNI, CDC27, CTBP1, DVL1,
EIF4E2, EP300, GNA12, LEF1, MAP4K5, MAPK1, MAPK3, MAPK9, MAP-
KAPK5, MAX, MDM2, MKNK1, PICALM, PRKAR1A, PRKCD, RAB1A, RASA1,
SKP2, TGFBR2, TUBB, TYMS }.
The same situation occurs in CNE2, many of these 71 genes in the largest cluster
in HK1 are classified in different clusters. They are
B={ ARRB2, BAD, CASP6, CCNNBIP1, CDC27, EIF4E2, HRAS, MAX, PAK1,
PARP1, PRKAR1A, PRKCD, RAB1A, RHOA, STAT1, TGFB1, TGFBR2 }.
Since CNE1 does not respond to the drug and CNE2 poorly responds to CYC202,
it may be of interest to examine genes in A \ B. However, these genes lie in
small clusters (some of these clusters are even singletons), and hence may not be
statistically significant. This leads to use principal component analysis to detect
any unusual genes, i.e., the outliers.
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2.3 Principal component analysis (PCA)
The goal of PCA is to reduce the dimensionality of the data while retaining as
much as possible of the variation present in the original dataset. Problems arise
when performing recognition in a high-dimensional space and significant improve-
ments can be achieved by first mapping the data into a lower-dimensionality space.
PCA allows us to compute a linear transformation that maps data from a high di-
mensional space to a lower dimensional space.
2.3.1 Selection of lower dimensional space
The notion of dimension reduction is to select a lower dimensional space. The
best low-dimensional space is determined as the best eigenvector of the covariance
matrix ofX and the best eigenvector is the eigenvector corresponding to the largest
eigenvalue. The eigenvectors are termed as principal components (PC) which can
be computed simply by using the following few steps. Let us assume that X be a
matrix of order N × p in which rows are objects. If we consider N genes in the
dataset and each gene having p microarrays corresponding to p time points then
the genes are in rows and microarrays are expressed in columns of matrix X, that









X11 X12 . . . X1p




XN1 XN2 . . . XNp

Step-1: Compute the mean as the average across each dimension, that





Step-2: Use the deviation form by subtracting mean from each of the
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value, Φi = Xi − X¯i.. The mean subtracted is the average across
each dimension.
Step-3: Construct the covariance matrix S = AAT whereA = 1√
N−1 [Φ1Φ2...Φp]
T .
This would be a square matrix of order p.
Step-4: Compute eigenvalues λ1 ≥ λ2 ≥ · · · ≥ λp ≥ 0 from the covari-
ance matrix S
Step-5: Compute eigenvectors e1, e2, ..., ep by using eigenvalues ob-
tained in step-4. Covariance matrix S is symmetric. Thus e1, e2, ..., ep
form a basis and a vector X or (X−X¯) can be expressed as a linear
combination of eigenvectors. Thus we can write




Step-6: Keep only the terms corresponding to K largest eigenvalues.
Now, the higher-dimensional space reduces to lower dimensional
space by using only K terms (K << p), that is,




where K << p.
Step-7: Selection of desired K is quite user-specific and most commonly




where η is user-defined parameter and most likely to be 0.9 or 0.95
and even in some cases 0.8 is also useful.
The linear transformation (Rp → RK) that performs the dimensionality reduction
is












 (X − X¯) = e
T (X − X¯)
Moreover, if S = {sij} is a p × p sample covariance matrix and its eigenvalue-
eigenvector pairs are
{(λ1, e1), (λ2, e2), ..., (λp, ep) : λ1 ≥ λ2 ≥ ... ≥ λp ≥ 0}







where Xj are obtained from matrix X for j = 1, 2, . . . , p. Now, if the observations
are centered by subtracting the mean then this has no effect on sample covariance
matrix S and so the same pairs of eigenvalue-eigenvectors would be obtained. Thus
the ith principal component is
Yi = e
T














: ||ak|| = 1, ak ⊥ ek−1, k = 2, 3, . . . , p} (2.7)
The fabulous features of the ith principal component is that its variance is equal
to the ith eigenvalue and is uncorrelated with any other principal components.
Besides, the total sample variance is trace(S) =
∑p
i=1 λi and so the proportion of
sample variance due to the ith principal component is λi∑p
j=1 λj
, i = 1, 2, ..., p.
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2.3.2 Error due to dimensionality reduction








The low-dimensional basis based on principal components (PC) minimizes the
reconstruction error
² =‖ x− xˆ ‖







2.3.3 Properties of PCA
The popular dimension reduction technique PCA has some very fabulous proper-
ties. Some of the useful features are discussed below:
(1) Scaling and standardization: PCs are dependent on the units the original
variables are measured. Thus, the standardizaion of the data is appreciated.
The most commonly used standardization procedure used is to transform
all the data to the zero mean and unit standard deviation. However, this
depends on the data to be analyzed and in some cases the standardization
may not so important.
(2) New variable and reconstruction: The new variables (βi’s) are uncorrelated
and their covariance matrix is given by
UTSU =

λ1 0 · · · 0
0 λ2 · · · 0
· · · · · · · · · · · ·
0 0 · · · λK

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Evidently, the covariance matrix encapsulates only the second order statistics
among the vector values. The new variables are linear combinations of the
original variables, and it is usually difficult to interpret their meaning.
(3) Loadings and scores: The vectors of loadings are orthogonal and the compo-
nent scores are uncorrelated.
(4) Outlier and influential observations: PCA has a very nice feature to detect
the outlier and influential observations.
(5) Geometrical interpretation: PCA projects the data along the directions where
the data varies the most. These directions are determined by the eigenvec-
tors of the covariance matrix corresponding to the largest eigenvalues. The
magnitude of the eigenvalues corresponds to the variance of the data along
the eigenvector directions.
2.3.4 Application of PCA to NPC data
Since there are many genes involved in a biological system finding a set of strongest
genes would be our goal in this section. At first we compute the eigenvalues and
eigenvectors from the dataset. To compute the eigenvalues and eigenvectors we
may either scale the data or may not scale also. Since our dataset comprises time-
course relationship and the expression levels have been measured by the same unit
of fold change we did not scale the data prior to the PCA. Moreover, values cor-
responding to the first time point (0h) is always constant and is unity. So, we
excluded this time point from further analysis, that is, the analysis was based on
the remaining five points (2h, 4h, 6h, 12h and 24h). We analyzed three cell lines
separately as well as combindly. When we combine three cell lines then there are
15 microarrays per gene of which 5 from each cell line. Computed eigenvalues and
their associated eigenvectors are incorporated in Table 2.1 and Table 2.2.
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By observing the last three columns of Table 2.1 we see that the cumulative propor-
tion of variance computed from the eigenvalues are pretty enough and the first two
components explaining more than 90% of the variation for each cell line. When all
the three cell lines (CNE1, CNE2 and HK1) are combined together then the first
two components (PC1 and PC2) in the last row of Table 2.2 account around 80%
of the variation. However, if we take into account the third PC (PC3) then the first
three components can account around 88% of the information of the whole dataset.
Our aim in PCA is to reduce the dimension by selecting a lower dimensional space.
Thus we would select the number of components such that this lower dimensional
space becomes a representative of the original higher dimensional space. Moreover,
we select the number of components those contain around 90% of variations. Thus
for the three cell lines two components are suitable, however, when we combine
them first two components can explain nearly 80% of the variation. It is still less
than 90% if we consider the first three components. We also introduce two other
alternative procedures to determine how many components to retain. The average
of all the eigenvalues (from Table 2.2) is 3.012666 and only the first three compo-
nents are greater than this average. Consequently, from the scree plot we observe
a sharp decline followed by a consistent smooth curve after the third component
(Figure 2.8). Thus three components would be retained in this case.
Number of time points are the number of dimensions and all the time points do
not contribute equally to the dimension reduction. Moreover, some time points
influence the reduction in a larger extent compared to the other and impact of
those time points reflect through the eigenvectors. To view the effect of individual
time points we have used the heatmap of absolute values of eigenvectors as the
sign of eigenvectors are arbitrary (Figure 2.9).
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Table 2.1: Eigenvalues and eigenvectors from three individual cell lines
Cell line PC 2h 4h 6h 12h 24h EV PV CP
PC1 -0.19129 -0.57864 -0.69501 -0.27482 -0.26462 3.47629 0.77700 0.77700
PC2 0.03463 -0.39096 -0.17776 0.5972 0.67654 0.60226 0.13500 0.91200
CNE1 PC3 -0.85251 -0.26343 0.44766 0.04807 -0.03339 0.17996 0.04030 0.95230
PC4 0.16825 -0.17605 0.09269 0.67952 -0.68583 0.13455 0.03010 0.98240
PC5 0.45511 -0.64183 0.52571 -0.32212 0.02828 0.07858 0.01760 1.00000
PC1 -0.17544 -0.51433 -0.3683 -0.39673 -0.6416 13.74175 0.71100 0.71100
PC2 0.04464 -0.80478 -0.09158 0.34481 0.47229 3.93937 0.20400 0.91500
CNE2 PC3 -0.92924 0.0947 -0.04093 0.35434 -0.01743 0.70742 0.03660 0.95210
PC4 -0.31719 -0.0578 0.15 -0.7732 0.52507 0.65641 0.03400 0.98600
PC5 -0.0559 -0.27476 0.91203 0.01749 -0.29881 0.26962 0.01400 1.00000
PC1 -0.18485 -0.52025 -0.52466 -0.55034 -0.34209 16.32753 0.76300 0.76300
PC2 0.42485 -0.29224 -0.30978 -0.06597 0.7961 3.16323 0.14800 0.91100
HK1 PC3 -0.86201 -0.20197 0.00037 0.22839 0.40495 1.62029 0.07570 0.98630
PC4 -0.20442 0.67288 -0.08579 -0.65262 0.26863 0.25654 0.01200 0.99800
PC5 0.02209 -0.38777 0.7883 -0.46334 0.11421 0.03617 0.00169 1.00000
Here EV, PV, and CP represents eigenvalue, proportion of variance and cumulative proportion respectively.










2 comp ~ 91.20%
CNE1: eigen values









2 comp ~ 91.50%
CNE2: eigen values






2 comp ~ 91.10%
HK1: eigen values








2 comp ~ 79.80%
3 comp ~ 88.10%
All cells: eigen values
Figure 2.8: Scree plot from eigenvalues































































































Figure 2.9: Heatmap of eigenvectors. The darker the cells the lower the influence.
White cells bear larger impact than the other. In the top left panel (a) 6h and 4h
have stronger impact on the first PC and that of 24h and 12h on the second PC.
For the third PC, 2h is the most effective time point.
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Table 2.2: Eigenvalues and eigenvectors from all cell lines combined
Cell line Time PC1 PC2 PC3 PC4 PC5 PC6 PC7 PC8
2h -0.06441 0.00616 -0.03791 0.01274 -0.09914 0.19659 -0.23008 0.30833
4h -0.1963 -0.10538 -0.13427 -0.13507 -0.1112 0.06944 -0.1522 0.23829
CNE1 6h -0.21793 -0.1044 -0.07731 -0.32083 -0.24891 0.17224 -0.11175 0.29385
12h -0.08059 0.06935 0.04445 -0.25831 -0.27932 0.14984 -0.09171 0.11484
24h -0.07975 0.0787 0.05797 -0.24102 -0.23921 0.04639 -0.42048 0.07120
2h -0.05955 0.17887 -0.08478 0.27419 0.16828 0.68184 -0.19925 -0.35030
4h -0.45215 0.02943 -0.46236 0.13861 0.25629 0.18806 -0.02289 0.02521
CNE2 6h -0.21445 0.24158 -0.11721 0.1183 0.31777 -0.03604 0.23388 0.56068
12h -0.15733 0.43024 0.03507 -0.21806 -0.40719 0.25859 0.62977 -0.18371
24h -0.24098 0.68117 -0.0766 0.12095 -0.08385 -0.50105 -0.30316 -0.13405
2h -0.11769 0.00152 0.5038 0.65774 -0.31006 0.10068 0.04251 0.32071
4h -0.38479 -0.28088 -0.00286 0.19012 -0.28433 -0.08389 -0.15251 -0.33211
HK1 6h -0.39075 -0.2831 -0.03206 0.04881 -0.10275 -0.19054 0.10386 -0.17722
12h -0.413 -0.22574 0.14512 -0.11363 0.19946 -0.12914 0.27965 -0.02401
24h -0.27386 0.12897 0.67195 -0.315 0.43065 0.11235 -0.16939 -0.09479
EV 25.41982 10.65899 3.73467 2.08377 0.94739 0.78484 0.44364 0.30427
PV 0.56300 0.23600 0.08260 0.04610 0.02100 0.01740 0.00982 0.00673
CP 0.56300 0.79800 0.88100 0.92710 0.94810 0.96550 0.97529 0.98202
Here EV, PV and CP stand for eigenvalue, proportion of variance and cumulative proportion respectively.
Only first 8 components are shown here as they account more than 98% of total variation.
As we have mentioned earlier that the number of components to be retained for
individual three cell lines are two and that for the three cell lines combined is
three. Thus, we can focus on those first two or three components. In Figure 2.9,
the white cell represents the higher influence and darker cells with lower influence.
Moreover, this kind of influence is scattered and are not giving a strict priority to
a certain time point. For CNE1 time points 6h and 24h have greater impact on
PC1 and PC2 respectively (panel (a) of Figure 2.9). Similarly, 24h and 4h have
strong contribution to PC1 and PC2 in CNE2 (Figure 2.9, panel (b)). Further, 12h
and 24h seem to be more influential on PC1 and PC2 respectively for HK1. From
panel (d) of Figure 2.9 we explore the strong impact of 6h of CNE1, 4h of CNE2
and 12h of HK1 on PC1 and that of 4h of CNE2, 24h of CNE2 and 6h of HK1
on PC2. However, the strongest impact of 4h from CNE1 is depicted on PC1, 24h
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of CNE2 on PC2 and that of 24h of HK1 on PC3 (Table 2.2). Now we compare
the boxplot (Figure 2.4) and explore that the interquartile ranges corresponding
to those time points are higher and so those time points (4h and 24h of CNE2 and
24h of HK1) contribute more in dimension reduction. In other words, expression
level changes significantly in those time points.
In dendograms, we observed that some genes expression patterns were not sim-
ilar to other and were clustered separately. Consequently, from the boxplot some
expression levels were found unusually higher than the others. Since genes with
unusual expressions may have some special biological activity. Outlier detection
method is a potential way to detect those unusually expressed genes. We have
plotted the first two component scores (PC1 against PC2) for CNE1 and have
identified that some genes are out of 95% ellipsoidal control region and some are
between 90% and 95% control region (Figure 2.10).
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Figure 2.10: Scores and elliposoidal control region for CNE1. Right panel is a
zoom plot of some part of left panel for a clear view of some genes. A 95% and
90% control ellipsoid are separated by black solid line and colored broken lines
respectively. Here X and Y axis represents PC1 and PC2 respectively.
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Figure 2.11: Scores and elliposoidal control region for CNE2. Ellipse represented
by black solid and broken lines are 95% and 90% control ellipse respectively.
Let us define
ERCNE1,0.95 = {CDKN2A,FOSL1, IFNA1, UBE2N,SPRY 2}
be the set of genes those lie outside the 95% control region and
ERcCNE1,0.95 ∩ ERCNE1,0.90 = {BRF1, CCNE2,MY C}
lies between the 90% and 95% control region where ERcCNE1,0.95 is the complemen-
tary set of ERCNE1,0.95. We have found that five genes are lying outside the 95%
control region and three genes are within the intersection of 90% and 95% control
region.
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Similarly,
ERCNE2,0.95 = {BIRC3, CDKN2A,FOSL1, IFNA1,MAP3K5, SPRY 2}
ERcCNE2,0.95 ∩ ERCNE2,0.90 = ∅
ERHK1,0.95 = {CCND1, CDKN2A,EGFR,FOSL1, IFNA1, IL1B, IL1A, SPRY 2}
ERcHK1,0.95 ∩ ER90HK1 = ∅
ERAll,0.95 = {BIRC3, CDKN2A,FOSL1, IFNA1, IL1B,MAP3K5, SPRY 2}
ERcAll,0.95 ∩ ERAll,0.90 = ∅
Thus we see that the 95% ellipsoidal control region and 90% control region detect
same outlier from CNE2. However, between 95% and 90% confidence ellipse no
gene is obtained for CNE2, HK1 and three cell lines combinedly (Figure 2.11-2.13).
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Figure 2.12: Scores and elliposoidal control region for HK1. Ellipse represented
by black solid and broken lines are 95% and 90% control ellipse respectively. Two
genes CCND1 and EGFR seem to very close.
2.3 Principal component analysis (PCA) 35

























PIP5K3M APK5CRS 3PRKACADNMT1CASP8U CC 6





ST T1O KAK 1MC 3
MAP3K5





X CC2KU 16F2MXM P3K2OSCTN IP1
PI 5 CRHOAE2F1MA 3 92
RKAG2
DK4CCND1 SI HACTB
H 8MF DDB 4PM2
M 14BI C2




































7C S 7HR 2LJ NSM 1RASMAP3 7I 2EI 2T 5 R10X
AGT BP1IKB BD4ABLR 6KA5L2LMA K2R
HEAB
M 4K5 C 2





























All cells: first two components
Figure 2.13: Scores and elliposoidal control region for all three cell lines combined.
Ellipse represented by black solid and broken lines are 95% and 90% control ellipse
respectively.
Once outlier genes are selected we can investigate the expression level of those
genes to identify which genes have more impact or highly expressed in one cell line
but lower impact or less expressed in another cell line. To capture this notion we
have used a within cell plot of all the outliers (Figure 2.14). Evidently, Figure 2.14
suggests that IFNA1 is the most highly expressed gene in all cell lines that causes
the induction of apoptosis. Consequently, BIRC3 is highly expressed in CNE2 (3rd
row of Figure 2.14) and FOSL1 is highly expressed in HK1 (4th row of Figure 2.14).
From the UniProtKB/Swiss-Prot entry information on genes and GO we find the
function of BIRC3 as anti-apoptotic and that of FOSL1 as positive regulation to
cell proliferation. On the otherhand, CDKN2A is moderately expressed in CNE1
and highly expressed in CNE2 and HK1. This gene causes induction of apoptosis
and negative regulation to cell growth, proliferation, cell-matrix adhesion, cyclin
dependent protein kinase activity and phosphorylation.
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From Figure 2.19-2.20, it is apparent that CCND1, EGFR, FOSL1, IFNA1, IL1A
and IL1B are highly expressed in HK1 compared to cell line CNE1 and CNE2. On
the other hand, BIRC3, CDKN2A, MAP3K5 and SPRY2 are highly expressed in
CNE2. But UBE2N is highly expressed in CNE1. UBE2N causes DNA double-
strand break processing, positive regulation of NF-kappaB transcription factor ac-
tivity, histone modification and histone ubiquitination. Thus it seems that due
to the use of CDK inhibitor CYC202, gene UBE2N expressed in a less amount.
UBE2N is less expressed in HK1, that is, the cell proliferation and DNA repair for
cell survival is reduced. On the other hand, CDKN2A seems to be upregulated in
HK1 that inducts the apoptosis. So these two genes seem to be more importantly
responded to the drug CYC202.
The first two PCs can be used to detect outliers those inflate the variance (for
higher variances). However, the last two PCs can also be used to detect quite
different kinds of outlier. In fact, the last two PCs select outliers those are apart
from the relationship of most of the genes. Thus selection of outlier genes based
on the last two PCs may also be useful. In this notion we have followed the same
procedure described earlier and have detected outliers based on the last two PCs
(Figures 2.15-2.17). Selected outlier genes have been incorporated in Table 2.3.
Consequently, the union of sets of genes selected as outlier from those plots have
been displayed in Figure 2.18 and Figure 2.19 to investigate the between cell vari-
ation.
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Figure 2.14: Within-cell plot of outlier genes. Top and bottom panels are out-
lier from three cell lines combindly and HK1 respectively. Middle two panels are
outlier genes obtained from CNE1 and CNE2. Here, CNE1: outlier all stands for
expression level from CNE1 for outliers detected from all cells combinedly.
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CNE1: Last two component scores
Figure 2.15: Outlier in CNE1 from last two PC, where solid and broken lined
ellipsoid are 95% and 90% control region respectively. Some genes outside the
95% confidence level are very close and hard to view. We have identified them by
using zoom plot and these gene groups are (AGTPBP1, CASP8) , (MAP3K7IP2,
TMPO, PIK3R1), and (GTF3C4, ZAK, BID, ABL1, TBP).
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CNE2: Last two component scores
Figure 2.16: Outlier in CNE2 from last two PC, where solid and broken lined
ellipsoid are 95% and 90% control region respectively. Two genes (CFLAR and
ERCC1) are very closely displayed at the bottom of the 95% confidence boundary
and have been traced out from the zoom plot.
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HK1: Last two component scores
Figure 2.17: Outlier in HK1 from last two PC, where solid and broken lined ellipsoid
are 95% and 90% control region respectively. Two genes (PTK2 and PRKACB)
are very closely displayed at the bottom-right of the 95% confidence boundary and
have been traced out from the zoom plot.
2.3 Principal component analysis (PCA) 41
















































































































































































































Figure 2.18: Outlier based on last two PCs, where CNE1, CNE2 and HK1 are
displayed by solid blue, broken red and dotted black lines respectively.
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Figure 2.19: Outlier based on last two PCs, where each gene is plotted for three
cell lines and CNE1, CNE2 and HK1 are displayed by solid blue, broken red and
dotted black lines respectively.
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Table 2.3: Outlier genes from 95% control ellipsoid
CNE1 CNE2 HK1 A B C D
ABL1 MAPK1 BCL2L1 ARFGAP3 BIRC3 CDKN2A CDKN2A CDKN2A
ADM MAPK8IP3 BIRC3 CASP10 CDKN2A FOSL1 FOSL1 FOSL1
AGTPBP1 MYC CDKN2A CCND1 FOSL1 IFNA1 IFNA1 IFNA1
AKT1 PIK3R1 CFLAR CDKN2A IFNA1 SPRY2 SPRY2 SPRY2
BID PTBP1 CHEK2 EGFR RPP14 UBE2N
BIRC3 PTK2B ERCC1 FOSL1 SPRY2
CASP8 RPP14 ERCC4 IFNA1
CDKN2A SKP2 FOSL1 IL1A
CTBP1 SMAD1 IFNA1 IL1B
FOSL1 SPRY2 MAP2K1IP1 PRKACB
FRAG1 TBP MAP3K5 PTK2
FRAT2 TMPO NFKB2 SPRY2
GTF3C4 TYMS RPP14 UBE2N
HIST1H4A UBE2N SNF1LK XRCC3
IFNA1 ZAK SPRY2
MAP3K7IP2
Here A, B, C, and D represent CNE1 ∩ CNE2, CNE1 ∩HK1, CNE2 ∩HK1, CNE1 ∩ CNE2 ∩HK1 respectively. First
two columns consist of 31 outlier genes come from CNE1. Both first two and last two PCs are used to find outliers.
From Figure 2.18 and Figure 2.19, we observe that ABL1, ADM and FRAG1 are
over expressed in CNE1 than in CNE2 and HK1 (Figure 2.18). Genes AGTPBP1,
ARFGAP3, BCL2L1, BID, BIRC3, CASP7, CASP8, CFLAR, CHEK2, ERCC4,
FRAT2, GTF3C4, HIST1H4A, MAP3K5, NFKB2, PTK2, PTK2B, SKP2, SNF1LK,
SPRY2, TMPO and TYMS seem to be over expressed in CNE2 than in CNE1 and
HK1 (Figures 2.18-2.19). Consequently, some genes like CCND1, EGFR, FOSL1,
IFNA1, IL1A and IL1B are most likely to be over expressed in HK1 than that
in CNE1 and CNE2. Now, we see that CCND1 looks like downregulated (down
trend) that affects progression from G1 phase to S phase of the mitotic cell cycle
and positive regulation of cyclin-dependent protein kinase activity. Further, EGFR
causes positive regulation of epithelial cell proliferation (GO:0050679) and seems to
be down trended in HK1. IL1A seems to be upregulated whereas IL1B seems to be
downregulated in HK1 (last row of Figure 2.18). IL1A functions negative regula-
tion of cell proliferation (GO:0008285) and IL1B is anti-apoptotic (GO:0006916).
Thus negative cell proliferation and induction to apoptosis related activities of
some genes in HK1 are observed.
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2.4 Summarizing the results
In this chapter, we have used the hierarchical clustering to cluster the genes in
different cell lines. Thereafter, we examine further the largest cluster of HK1
(fully responded cell line) and explore the genes of that clusters in different cell
lines. Some co-clustered and unusually clustered genes are identified. Perhaps
these genes may be of interest to check with the biologists to explore the molecular
mechanism behind them. Apart from the co-clustered and unusually clustered
genes, the biologists may want to take a closer look at the unusually expressed
genes as identified by the PCA. We further plotted, Figures 2.18-2.19, the time-
course variation of these genes to facilitate their observations. One possibility to
look at is the time-course coregulatory and reverse regulatory relationship of these




Time-course microarray experiments potentially provide insight into the time-
lagged coregulation of gene(s). Several authors have proposed different method-
ologies to view the time-course relationship among genes or set of genes. Edge
detection method proposed by Chen et al. (1999) assigned a higher score for close
edges than the edges are further apart. So, the genes pair with higher score suggests
an activation relationship. Although this method considers more localized similar-
ities, however, this is computationally inefficient. The Cross-correlation Method
proposed by Kato et al. (2001) uses the computation of correlation coefficient that
accounts the time-lag property and differs from the traditional Pearson correlation
coefficient. This is useful to identify the global similarity but not to account the
local temporal effect on the similarity measure between the genes. Since these two
methods did not allow the directional change Kwon et al. (2003) proposed the
event method that enables to guide the directional change. This algorithm catego-
rizes the directional changes as an event and there are three events namely Rising
(R), Constant (C), and Falling (F) measured by the slope of the expression value
45
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at each time interval. Finally, global alignment via Needleman-Wunsch algorithm
is applied to match the string of events for two genes.
Considering the more temporal change Yeung et al. (2004) proposed Dominant
Spectral Component Method based on the autoregressive modeling technique that
decomposes the time-series expression sequences into spectral components. Be-
sides, the correlation between two sequences is formulated as a sum of scaled
sub-correlations. Although the temporal effect is included in this method to com-
pare only gene-to-gene relationship, but not suitable for comparing multiple genes.
Considering the limitations of the above studies Ji and Tan (2005) proposed q-
clustering procedure to select set of genes under certain pattern or sub-patterns.
Although their method enables us to find the time-lagged sub-pattern, however,
they used 0.1 as the threshold value (to be defined later). A natural question to
ask is 0.1 a good choice? In the next section, we wish to address this question.
Model based profile analysis and identification of significant expression patterns
can be informative to infer the regulatory activity (coregulation) of a set of genes
under different experimental conditions. Although hidden markov model (HMM)
based clustering (Schliep et al., 2003) and autoregressive model based method (Ra-
moni et al., 2002) can easily handle this problem, however, their methods are not
suitable for small number of time points. There are only six non-equispaced time
points in our NPC data. If we use two regression parameters just to account the
up and down trend then the first two time points can not be used. Besides, the
HMM based profiling requires more time points than the number of states used
in the Markov chain. The continuous representation of Bar-Joseph et al. (2003a)
based on the B-spline and EM algorithm is suitable for more than 10 time points
(Ernst et al., 2005). Since we have only six time points so we used the methods
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proposed by Ernst et al. (2005). Besides, we conducted a gene ontology (GO)
based profile analysis as in Ernst and Bar-Joseph (2006).
3.1.1 Pattern profiling of gene expression
Let us assume that we have N genes under study. After the exclusion of missing
genes (genes with missing values) we have N1, N2, and N3 available genes in three
cell lines CNE1, CNE2, and HK1, respectively. We would like to classify the genes
in some distinct classes. Let Xg,i,tk be the value of gth gene from the ith cell-
line at time point tk for k = 1, 2, 3, 4, 5, 6. Evidently, we can express the data
space as S = {Xg,i,tk : g = 1, 2, ...Ni; i = 1, 2, 3; tk ∈ T}. Of course, in our study
N1 = N2 = N3 = N . Let us denote Rk =
Xg,i,tk+1
Xg,i,tk
, k = 1, 2, 3, 4, 5. Thus we get
three types of characteristics of Rk shifting up, constant, and drifting down. We
can express this as
Rk

> 1 if Xg,i,tk+1 > Xg,i,tk
= 1 if Xg,i,tk+1 = Xg,i,tk
< 1 if Xg,i,tk+1 < Xg,i,tk
(3.1)
To classify the genes in different groups we follow the procedure of (Ji and Tan,
2005). Although they have used the normalization threshold equal to 0.1, however,
there are possibilities to select the optimal threshold (c in equation 3.2). Here we
treat this as a parameter and formulate a statistically reasonable value. Based on
their work we classified different pattern classes by the following threshold
sk =

+1 if Rk ≥ 1 + c
0 if 1
1+c
< Rk < 1 + c
−1 if Rk ≤ 11+c
(3.2)
where c is to be chosen from (0,1). For six time points we have 35 = 243 possible
patterns and so an NPC gene will be classified into one of these 243 patterns.
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Let P be the set of 243 patterns, that is, P = {+1, 0,−1}5 where each pattern is of
length 5. As for example, 11111, -1-1-1-1-1, 00000 and 1-101-1 are some patterns.
To select the optimal value of c we plot the number of classes for each cell-line for
c ∈ (0, 1). Let Gi,j be a set of genes corresponding to the pattern Pi and cell line
j where j = CNE1, CNE2, HK1. Now, for the jth cell line the index set Ij is
given by
ICNE1 = {i : Gi,CNE1 6= ∅; 1 ≤ i ≤ 243}
ICNE2 = {i : Gi,CNE2 6= ∅; 1 ≤ i ≤ 243}
IHK1 = {i : Gi,HK1 6= ∅; 1 ≤ i ≤ 243}
Some patterns may not match with the gene expressions and may not be included
in the index sets. Thus ICNE1 is an index set containing the patterns those include
at least one gene and the cardinality of this index set is just the number of ele-
ments. Therefore, the cardinality of index set ICNE1 is obtained by counting the
number of patterns containing at least one gene. A similar procedure is followed
for CNE2 and HK1. Total number of patterns required in all three cell lines is
then the cardinality of the index set ICNE1∪CNE2∪HK1 = ICNE1 ∪ ICNE2 ∪ IHK1.
To depict the effect of the threshold (c) we plot the cardinality against c. The
cardinality is expected to first increase and then decrease as c increases. The
optimum c can be selected based on the stability (almost stable or small change)
of the plot. To implement this procedure we used our data set consisting of three
cell lines. Results obtained from the three cell lines have been incorporated in table
and displayed by a figure (Table 3.1 and Figure 3.1).
Now, we observe the number of genes common within a profile over different cell
lines. Let gr ∈ Gij denotes that the rth gene from jth cell line is contained in
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Table 3.1: Number of profiles for different threshold (C)
Threshold(C) 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
CNE1 58 82 89 87 87 81 64 59 53
CNE2 48 67 67 67 67 67 66 63 56
HK1 47 55 55 55 55 55 55 54 40
CNE1 ∪ CNE2 ∪HK1 106 132 125 123 123 120 116 111 104
pattern Pi.
ICNE1∩CNE2 = {r : gr ∈
243⋃
i=1
{Gi,CNE1 ∩Gi,CNE2} 6= ∅; r ∈ (1, 2, ..., 384)}
Similarly,
ICNE1∩HK1 = {r : gr ∈
243⋃
i=1
{Gi,CNE1 ∩Gi,HK1} 6= ∅; r ∈ (1, 2, ..., 384)}
ICNE2∩HK1 = {r : gr ∈
243⋃
i=1
{Gi,CNE2 ∩Gi,HK1} 6= ∅; r ∈ (1, 2, ..., 384)}
ICNE1∩CNE2∩HK1 = {r : gr ∈
243⋃
i=1
{Gi,CNE1∩Gi,CNE2∩Gi,HK1} 6= ∅; r ∈ (1, 2, ..., 384)}
Cardinality of those index sets are the number of genes common to a similar pattern
between or among cell lines. Results on such cardinalities have been displayed in
Figure 3.2. For c = 0.2 we observed that few genes are sharing common patterns
over different cell lines. Since CNE1 does not respond and both the CNE2 and
HK1 respond to the drug CYC202 it is apparent that the degree of independence
between CNE2 and HK1 would be less than that of CNE1 and CNE2 or CNE1
and HK1. So, more genes are likely to be common between CNE2 and HK1
within a particular pattern. Thus from the assumption that the three cell lines
are independent, we may say that the optimal threshold would be c = 0.2. Even
if we do not assume the independence of cell lines the optimal threshold would
3.1 Introduction 50




















Figure 3.1: Number of patterns for c-value














CNE1 & CNE2 & HK1
Figure 3.2: Number of genes common to same pattern. Solid black line indicates
number genes sharing same pattern from CNE1 and CNE2. Broken red and dot-
ted black lines represent common genes from CNE1 & HK1 and CNE2 & HK1
respectively
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be c = 0.2 (Figure 3.1). Therefore, we select c = 0.2 for further computation.
Patterns of some genes selected from the PCA (Chapter 2) are provided in Table
3.2.
3.1.2 Activation and Inhibition
In time-course gene expression experiment, it is of interest in identifying time-
lagged relationships between or among a set of genes. This will provide insight
about how genes coregulate, activate or inhibit one another. Unlike the event
method (Kowan et el., 2003), Ji and Tan (2005) introduced the q-cluster genera-
tion procedures to capture the time-lagged activation and inhibition. Interestingly,
this procedure searches for similar subsequence of length q− 1 over some q consec-
utive time points to investigate the coregulation. The q-cluster may be obtained in
two genes at the same time point or at two different time points. So, two different
time points is an indication of activation (activity with the same direction). Simi-
larly, the search for an inhibition (activity in reverse direction) is just the opposite
to that of activation (activity in same direction).
After the transformation of the matrix in patterns there are three possible entries
for each time points. Thus there are 3q−1 possible clusters where q is less than or
equal to the number of time points and in our data q may be at most 6. Each q-
cluster possesses a unique identification number called q-clusterID. The identifier
can be generated as follows. Assume V = {v[1], v[2], ...., v[q − 1]} be a pattern
where v[i] ∈ {−1, 0,+1} ∀i ∈ [1, q− 1]. Then the q-clusterID of V can be given by







 v[i] if v[i] = 0 or 12 if v[i] = −1
Evidently, q − clusterID ∈ [0, 3q−1]. Here q is a user defined parameter. For ex-
ample, the subsequence 001100 has q − 1 = 6 and so the q − clusterID for this
subsequence would be 0 + 0 + 37−1−3 + 37−1−4 + 0+ 0 = 36. So, with the decrease
of the q-cluster size (q) the number of q-cluster decreases and fewer subsequences
are obtained in many genes with the same sub-patterns. Now, if for the gene g1
this q-cluster starts at 10th position and that for gene g2 starts at 12th position
then we may say that most probably g2 is activated by g1 after 2 time periods.
Similarly, the inhibition property can also be found but with examining the op-
posite sign of the subsequence (or pattern). If the starting point of this pattern
(or subsequence) for both the genes are same then this is termed as time-lagged
coregulation, that is, after certain time periods both genes coregulate. Here, one
problem is to determine the activation-inhibition property for the match of 0’s. If
more 0’s are included in the pattern the negation of the pattern becomes same for
all 0’s. Therefore, the number of meaningful q-cluster is always less than 3q−1.
Although this is a popular procedure to find a time-lagged relationship among the
gene sets, however, there are problems associated with the threshold and classifi-
cation criterion. Since there are three categories, namely -1,0, and +1 where the
ratio of fold change from previous time point is classified as 0 if that lies within
the lower and upper bound. The main caveat is that the expression level within
this class is not static and may vary between two genes with opposite direction.
Although it is assumed that the interval is very small and so the variation may be
ignored, however, if the interval increases with the increase of the threshold (c).
Our data comprises six time points and under this pattern and threshold selection
we have 35 = 243 patterns. So, the possible study on time-lagged relationship is
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limited to first and second order only. Since we need at least three consecutive
time points to observe the time-lagged behavior (coregulation or reverse regula-
tion) we analyze such relationship only for the first and second order lag period
for the pattern classes (Table 3.2). Although we display the coregulated patterns
with time-lag, however, it is easy to find the reverse relation just by multiplying
the pattern (or sub-patterns by -1). Just to explore the relationship let us consider
two genes from CNE1 with patterns ADM (-111-11) and CFLAR (1-1-111). Now,
if we multiply one of these two patterns by -1 then up to the last time period
both are same, that is, they may have some reverse regulatory relationship. In
other words, when one is activating another is inhibiting. Similarly, CFLAR and
CHEK2 have same expression pattern both in CNE2 and HK1. Although in CNE1
there are differences in 0 positions of CHEK2, however, this does not imply that
the expression level is constant rather varies with a very limited direction. Thus
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3.2 Model based profile analysis
Profile analysis for long time-course expression is mathematically very rich for
model based approaches. However, when there are very few time points then those
methods found to be mathematically inappropriate. Generally, predefined profiles
are matched and fitted with the expression profiles. But this requires the prior
knowledge about the shape of the curve and very often such knowledge are not
available (Lu et al., 2004). When there are few time points and several repeats
linear splines (De Hoon et al., 2002) and cubic B-spline (Bar-Joesph et al., 2003a)
are fitted to cluster gene expression curves. Most of the previous methods either
require prior knowledge or many time points or repeats or predefined profiles. Here
we would use the method of Ernst et al. (2005) and Ernst and Bar-Joseph (2006)
to select a set of significant model profiles.
3.2.1 Selection of model profiles
Prior to the selection of model profiles the raw expression is generally normalized
either by log ratio or by subtracting the expression level for the first time point.
However, this is optional and user dependent. If the data set is not normalized
then add one additional zero (0) before the first time point (Ernst and Bar-Joseph,
2006) and conduct the remaining procedure.
For n time points this methods proposed (2κ + 1)n−1 distinct profiles where κ is
an user-defined parameter and represents the amount of change a gene can exhibit
between successive time points. For n = 6 and κ = 1 we get 35 = 243 model
profiles. Thus, the number of model profiles grows with the number of time points
and the change parameter (κ). Therefore, selection of a subset of these model
profiles is very important to reduce the sparsity of huge contents.
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Let Q be the set of (2κ + 1)n−1 model profiles and we are interested in H ⊂
Q with m profiles such that the minimum distance between any two profiles in










Let b(H) = minp1,p2∈H d(p1, p2) be the minimum distance between profiles in H
and we want to maximize this. Consequently, assume that b(H ′) be the optimal
value of b(H) achieved by the maximization condition stated above. But finding
such a set H ′ is NP-Hard (Ernst et al., 2005). A problem is assigned to the NP
(nondeterministic polynomial time) class if it is solvable in polynomial time by
a nondeterministic tuning machine. A problem is NP-hard if an algorithm for
solving it can be translated into one for solving any NP-problem (nondeterministic
polynomial time) problem. Besides, an approximation that guarantees a solution
that is better than 1
2
b(H ′) is also NP-Hard. To overcome this problem Ernst et
al. (2005) proposed a greedy algorithm that finds a set of profile H with b(H) ≥
1
2
b(H ′). The algorithm has been provided below:
(1) Let us assume that p1 be the profile that always goes down with one unit
between time points. It is to note that at the initial stage we select one of
the two extreme profiles (either always goes up or down).
(2) Define H to be a collection of some profiles. For the time-being H = {p1}.
Since this is a recursive algorithm soH would be updated after each iteration.
(3) Add another profile p such that maxp∈(Q\H)minp1∈H d(p, p1), that is, we select
a profile that is distinct to the previously selected profiles.
(4) Update the profile set by H = H ∪ {p}
(5) Repeat steps (3)-(4) to find a set of m profiles.
3.2 Model based profile analysis 58
The above algorithm performs m iterations to select a set of m profiles and
each of this takes at most m(2κ + 1)n−1 times. Thus the total running time is
O(m2)(2κ+1)n−1. In this algorithm, distance measure is computed from the Pear-
son correlation coefficient and m is a user-defined number. In practice, user can
select a higher value of m, sort profiles by the number of genes and remove profiles
which are not matched with any gene expression.
3.2.2 Identification and grouping of significant profiles
Let M be a set of m model profiles and G be the set of genes where each gene
is supposed to be assigned to a model profile in M. Define eg be the expression
profile for gene g. Then for each gene g ∈ G we assign it to a model expression mi
such that d(eg,mi) is minimum. We count the number of genes assigned to each
model profiles and denote by t(mi) for the profile mi for identifying model profiles
that are significantly enriched.
The formal assumption is that the data are independent. A permutation argument
is used to quantify the expected number of genes. There are n! possible permuta-
tions for n time points. For each permutation σ genes are assigned to their closest
model profile. Under the null hypothesis, the expected number of genes assigned








σ is the number of genes assigned to model
profile mi for permutation σ. Since different model profiles may have different
number of expected genes so Ei 6= 1m |G|.
Furthermore, each gene is assigned to one of the profiles and so we can assume that
number of genes assigned to each profile is a binomial variable with parameters |G|
and Ei|G| . Thus, the uncorrected probability of getting t(mi) genes assigned to profile




. If only one model expression is
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tested then we can use P (X ≥ t(mi)) ≤ α. Since we are testing m model profiles
we need to correct for the multiple comparison. Thus we apply the Bonferroni
correction and the statistically significant number of genes assigned to mi can be
computed by using
P (X ≥ t(mi)) < α
m
(3.4)
3.2.3 Clustering significant profiles
A greedy algorithm is used to cluster the significant profiles. This is conducted in
few steps
(1) Initialization of cluster: Let Ci = {pi}
(2) Look for a closer profile: Select another profile pj which does not belong to
Ci. Include pj in Ci if the distance d(pj, pk) ≤ δ for all pk ∈ Ci.
(3) Repeat the same procedure until all the profiles are clustered.
3.2.4 Actual and expected gene set size enrichment
The actual size based enrichment is that in which the enrichment is computed
using the hypergeometric distribution based on the number of genes in the set of
interest. Let N be the number of genes in a microarray and so be the number of
genes in the GO (Gene Ontology) category of interest. If sr is the number of genes
assigned to profile mr then the probability of ν or more genes in the intersection
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GO category enrichment p-value can be computed by using the binomial proba-
bility. Let se be the expected size of profile mr then the probability of getting
ν genes both in the GO category and profile mr is computed from the binomial














Both the actual size and expected size enrichment have their specific advantages.
An advantage of actual size enrichment occurs in the case in which the genes of
multiple independent processes are likely to have the same temporal expression
pattern. In this case a temporal expression pattern could be very significant in
terms of the number of genes assigned versus expected but no GO category will
appear enriched under an actual size enrichment test. However, under an expected
size enrichment test the GO categories could correctly be identified as being en-
riched. This is also useful for ordering temporal expression profiles to determine
which are most relevant to a given GO category (Ernst and Bar-Joseph, 2006).
3.2.5 Comparison across experimental conditions
Model profiles selected from two different experimental conditions are compared.
The hypergeometric distribution is used to compute the significance of overlap
between gene sets of model profiles from two experiments. Since the model profiles
do not depend on the gene expression level they will remain unchanged between
experiments and it is possible to detect significant set of genes with the same
expression profiles across experiments (Ernst and Bar-Joseph, 2006).
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3.2.6 Numerical results
To conduct the model based profile analysis we have used the JAVA based time-
course expression miner, STEM, developed by Ernst and Bar-Joseph (2006). First
of all we generated a set of model profiles following the methods narrated in Subsec-
tion 4.2.1, and then identified a set of significant profiles by using the procedures
mentioned in Subsection 4.2.2. By using the procedure of Ernst et al. (2005)
and Ernst and Bar-Joseph (2006), we selected 50 model profiles for each cell line.
The model profiles have been arranged with respect to the enrichment probability
and the significant profiles have been displayed into colored boxes (Figure 3.3).
We observed that genes in CNE1 were clustered in 16 model profiles of which 9
are significantly enriched (colored boxes). For some model profiles the enrichment
probabilities were insignificant and very few or a single gene may be assigned.
Since the expression level of some genes may be extreme (very high or low values
compared to the most of the genes) or may have a very minor change between
time points so they are most likely to be classified under distinct model profiles.
From the second row of Figure 3.3, we observed that the Model Profile-28 is not
significantly enriched and contains two genes IFNA1 and MYC which were selected
as outliers (Figure 2.18 and Figure 2.19). Consequently, for Model Profile-45 we
observe that the change of expression is very low and two genes have been shown
below:
Gene 2h 4h 6h 12h 24h
PSMB9 1.27 1.11 0.57 0.28 0.28
STAT6 1.28 1.11 0.56 0.28 0.56
From Figure 3.3, it seems that the genes belong to the Profile-39 are up-regulated
and those belong to Profile-8 (there were no genes in this profile and was not shown
in the figure) are down-regulated. Genes assigned to that profile are listed below:
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CNE1 (Profile-39): CDKN2A ERCC3 CCNA2 UBC GTF2B CDKN1B FADD CCNB1 CASP3 RAB5A USP8 SPRY2 RASSF1
CDC2 ERCC4 UBE2N MAPK7 BRMS1 CDK7 EIF2S1 HEAB APC DAXX PRKACB XPC ACBD3
MAP3K4 VEGF JAK2
CNE2 (Profile-39): CDKN2A HIST1H4A CCNE2 DNMT1 UBC GADD45A USP16 MAP3K9 SKP2 ADM XPA SPRY2
RASSF1 FAS TUBB BIRC3 FRAT2 CDK2 CDK7 AKAP1 PPP1R10 MAX SMAD4 BCL2L11 RRM1
MAP4K5 CRK PICALM HSPA4 HIF1A ORC1L FRAG1 TBP GTF3C4 CTBP1 ORC6L SRF MAP3K6
HK1 (Profile-39): CDKN2A UBE2N EIF2S1 FOSL1 IL1A
By using the pairwise comparison among the cell lines we found some common
genes from CNE2 and HK1 only (Figure 3.4). Among the 13 genes assigned to
Profile-22 in CNE2, 9 were found in Profile-36 of HK1. Similarly, 39 genes are found
to be common between the Profile-46 from both CNE2 and HK1. This group of
genes are more likely to have same activity pattern both in CNE2 and HK1. But,
we do not find any gene common between any two profiles both from CNE1 and
CNE2, as well as from CNE1 and HK1. Genes sharing the same expression profiles
in CNE2 and HK1 are given below:
Left panel: DMTF1 SIAH1 FADD MAP3K7 ERCC4 MAPK7 SMAD1 HEAB DAXX
Right panel: YWHAZ HIST4H4 ELK4 ARFGAP3 HSPBAP1 PRKACA CASP6 MAP2K3 CSNK1A1
STAT1 MAP3K5 CASP10 PDGFC CTNNBIP1 PTK2 BIRC2 RPLP0 XRCC5 PAK1
DNMT2 PTK2B RASA1 IKBKB RPS6KA5 MKNK1 ARRB2 GSK3B MAP2K2 TGFBR2
PRKCD FOXO1A XRCC1 ERCC1 18S VASP PSMB9 STAT3 ORC3L RAN
Furthermore, we use the Ernst and Bar-Joseph (2006) methods to analyze the
gene ontology (GO) category. Since there are only 275 genes with full infor-
mation and are under study, Go category analysis found only very few genes.
Some genes which are related to positive regulation of apoptosis are ZAK, ABL1,
BAK1, BID, MAP3K5, TRAF2, CUL1, CASP8, FAS, BRCA1, BAX, CASP10,
MAPK8, TUBB, MAPK1, TGFB1, BAD, TRADD, AKT1, CFLAR, CHEK2,
ERCC2, CDKN2A, ERCC3, CDKN1B, FADD, CASP3, DAXX, PTEN, DIA-
BLO and TP53 (Figure 3.5). Similarly, some genes obtained from JNK-Cascade
(stress activated protein kinase signaling pathway) are MAPK8IP3, ZAK, MAPK8,
DAXX, MAP3K11, MAP4K3, MAP3K5, MAP3K9, MAP4K5, MAP4K2 and IL1B.
Further, GO category enrichment based on Ernst and Bar-Joseph (2006) finds
CSNK1A1, PORCN, CTNNB1, GSK3B, AXIN1, DVL1, CTNNBIP1, LEF1, BTRC,
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Figure 3.3: Genes classified under different profiles. First two rows are profiles for
CNE1, 3rd-4th row for CNE2 and 5th-6th row for HK1. Profiles in colored boxes
are significantly enriched. In each box, top-left and bottom-left values indicate
Profile-ID and number of genes belong to that profile respectively. For the box in
first row and first column, there are 66 genes under profile-44.
Figure 3.4: Common genes between CNE2 and HK1. In each box, top-left value
is the profile-ID. For the left panel, profile-22 (left box) of CNE2 is compared with
profile-36 (right box) of HK1 and 9 common genes were found. Bottom-left corner
of right box in each panel contains number of genes common to this profile and
uncorrected p-value for enrichment as well as the top-right value is the correlation
between two profiles.
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FRAT2 and APC on Wnt receptor signaling pathway (Figure 3.5).
Figure 3.5: GO categories on some pathways from HK1
3.2.7 Summarizing the results
We examined the time-course regulatory relationship of those genes identified in
Chapter 2. Having done so, however, we do not observe any interesting time-
course regulatory relationship among them. One possible cause is that very few
genes (generally thousands of genes are studied but in this experiment we have only
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380 genes) were studied. Moreover, their gene expressions were measured over few
time points.
In Chapter 2, we encountered some difficulties using cluster comparison between
two cell lines as the clusters were very different. In this chapter, we tried model
based profile analysis to cluster both genes and gene ontology category. The main
advantage of this model profiles is that the use of identical profiles in all cell lines, as
for example, profile-46 (0,2,2,1,1,2) in CNE1, CNE2 and HK1. When we compared
different profiles we found only some common genes in HK1 and CNE2 sharing the
same profiles. Since HK1 responded fully whereas CNE2 responded poorly, so the
biologists may want to take a closer look at these uncommon genes, perhaps this
may aid some understanding of some biological processes involved.
Although in this chapter we have used gene set size enrichment both for clustering
and GO categories but are still inconclusive. So we aim to find some differential
gene expression associated with some GO categories. In the next chapter, we
identify differentially expressed genes.
Chapter 4
Differential Gene Expression Analysis
4.1 Introduction
Changes in expression level over different biological conditions help identification
of differentially expressed genes. This can be studied from the static or dynamic
viewpoint both from replicated or unreplicated experiments. The fold change rule
relies on the fold increase or decrease cut-off between two experimental conditions.
A major problem of this method is that there is no statistically guided method
to choose a cut-off value. A critical review on SAM, SAMROC and Zhao-Pan
methods has been conducted by Kim et al. (2006). However, most of the methods
are only applicable to replicated measurements and in static condition. A few
studies, such as Bar-Joseph et al. (2003b) studied the continuous representation
of time-series expression. However, Bar-Joseph et al. (2003b) method also only
applies to replicated measurements. If a cubic B-spline is used over five time points
then this method requires at least 10 values of which two from each time point.
But repeated measures may not always available in experiments. Another problem
is that this method cannot compare curves from three or more different biological
conditions, that is, only two curves can be compared at a time. Motivated by this
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Storey et al. (2005) used B-spline to approximate the population mean curve and
find differentially expressed genes. However, this method is suitable only when
there are more individuals under study and more than one expression level at
each time point. Similarly, the EDGE method developed by Leek et al. (2006)
used the method of Storey et al. (2005) and an independent setting where it is
assumed that each individual is studied only at a single time point. Essentially
this requires more individuals under study to proceed with a time-course setting
and to perform longitudinal modeling. Although this method can compare more
than two biological conditions in time-course experiment, however, sampling from
individuals is required. But unreplicated time-course expression with multiple
biological condition setup is necessary in some experiments and DeCook et al.
(2006) developed a procedure to handle such problem. Recall that our dataset
consists of three cell lines with a single fold change at each of five time points in
hours (2h, 4h, 6h, 12h and 24h). In the next sections, we see how this method can
be implimented.
4.1.1 Hypothesis
Let us consider an unreplicated multiple-treatment time-course experiment consists
of J treatments and T time points. So there are M = J × T microarrays for
each distinct gene. Let Yg,j,t be the fold change of gene g = 1, 2, . . . , 380 under
treatment j = CNE1, CNE2, HK1 at time point t = 2, 4, 6, 12, 24. In our data
set, there are five time points in hours 2h, 4h, 6h, 12h and 24h, and three cell lines
(or treatments): CNE1, CNE2 and HK1. The fold change of each gene can be
expressed as the expected treatment-time combination and random error term:
Yg,j,t = µg,j,t + ²g,j,t (4.1)
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where ²g,j,t ∼ iid(0, σ2g). Evidently, gene whose fold change differs significantly
from the overall mean pattern is supposed to be biologically interesting. The mean
structure of a gene with null hypothesis depends on neither treatment nor time and
can therefore be fully described by the single parameter µg. Thus we can proceed
to test the following hypotheses:
H0g : µg,j,t = µg against H1g : H0g not true (4.2)
4.1.2 Model selection
In time-course microarrays, the expression level of genes may follow different pat-
terns ranging from a straight line to a complex curve. Thus we need to take
into account a set of candidate models consisting of all possible regression mod-
els involving treatment effects, terms polynomial in time, and interaction between
treatment and polynomial terms. A set of possible models are shown in Table 4.1.
Table 4.1: List of candidate models
Models
Model Term 1 2 3 4 5 6 7 8 9 10 11 12 13
Group x x x x x x x x x x
Time x x x x x x x x x x x x
Time2 x x x x x x x x x
Time3 x x x x x
Group:Time x x x x x x
Group:Time2 x x x
Group:Time3 x
Here “x”represents inclusion of terms in the model.
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Now, we fit the above mentioned models and compute sum of squared residuals
(SSR) . Similarly, we fit an overall mean model that includes only a constant
population mean effect and compute SSR. Using the SSR from both the models we
compute the observed F-statistic for each of the 13 models in the Table 4.1. Thus










, s = 1, 2, . . . , 13 and df(.) means degrees of freedom.
Thus for each gene we get a set of observed F-statistics
F0 = {F1,0, F2,0, · · · , F13,0} (4.4)
To generate a possible realized vector of F-statistics under H0, we permute the
labels of M microarrays and recompute the vector of F-statistics
F ∗1 = {F ∗1,1, F ∗2,1, · · · , F ∗13,1} (4.5)
From a possible M ! permuted samples we select a subset of B permuted datasets
and compute the permutation distribution of F-statistics for each gene
F ∗ = {F ∗1 , F ∗2 , · · · , F ∗B} (4.6)
For each gene the model selection method selects the model whose F-statistic is
the most extreme when compared to the permutation distribution of F-statistics
computed from the same model (DeCook et al., 2006). Thus the approximate







, where F ∗s,0 ≡ Fs,0 (4.7)
Now we select the best model with the smallest permutation p-value, that is, choose





Similarly, we compute p∗mb,b for each of the permutations for b = 1, 2, . . . , B.
Thus from the permutation distribution we have a sequence of test statistics
{p∗m1,1, p∗m2,2, . . . p∗mB ,B}. By comparing the observed test statistics to the permu-










The above mentioned computation is conducted for each gene separately. Under
the null hypothesis, each p∗∗ behaves as a conservative p-value such that PH0(p
∗∗ ≤
α) ≤ α for any α ∈ [0, 1]
4.1.3 q-value cut-off and false discovery rates
To select differentially expressed genes we use the q-value as a measure of signifi-
cance (Storey and Tibshirani, 2003). The q-value can be computed by the following
general algorithm:
(1) Let p(1), p(2), · · · , p(N) be the increasing ordered p-values. For simplicity of
notations we have used p(i) in lieu of p
∗∗
(i). Genes are also ordered with the
ordering of the p-values.
(2) For λ ∈ R = {0, 0.05, · · · , 0.90} we calculate
pˆi0(λ) =
#{pj > λ; j = 1, 2, · · · , N}
N(1− λ) (4.9)
Note here that R is a user-defined set of λ values.
(3) Let fˆ be the natural cubic spline of pˆi0(λ) on λ. Then the proportion of genes
that are not differentially expressed is estimated as
pˆi0 = fˆ(max(R)) = fˆ(0.90) (4.10)





#{pj ≤ t; j = 1, 2, · · · , N} = pˆi0p(N) (4.11)








(6) The estimated q-value for the ith most significant gene is obtained as qˆ(p(i)).
The false discovery rate (FDR) for selecting significant p-value ≤ t is implicitly
obtained in the above algorithm as
̂FDR(t) =
Npˆi0t
#{pi ≤ t; i = 1, 2, · · · , N} (4.13)
Once q-value is computed we can select a cut-off value to find differentially ex-
pressed genes. Consequently, we can plot the expected false positives, number of
significant tests and q-value cut-off. The cut-off value can be determined based on
those plots.
4.2 Numerical results
We used the above mentioned procedure of DeCook et al. (2006) to find differen-
tially expressed genes. We have five time points under study and so there would
be 10 microarrays in each gene within two groups. Firstly, we compute the permu-
tation distribution of test statistics by using 2500 permutations following DeCook
et al. (2006). Secondly, we compute the q-statistic based on the algorithm pro-
posed by Storey and Tibshirani (2003). We get 80 differentially expressed genes
for a q-value cut-off of 0.005 (Table 4.2). Consequently, q-value and expected false
positives are displayed in Figure 4.1.
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Figure 4.1: q-value cut-off and expected FDR for CNE1 and HK1


























































Figure 4.2: q-value cut-off and expected FDR for CNE1 and CNE2
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Table 4.2: Differentially expressed genes
CNE1vsHK1 CNE1vsCNE2
Gene p.value q.value Gene p.value q.value
PARP1 0.24000 0.33017 PPP1R10 0.28000 3.58502
RASSF1 0.32000 0.33017 CDK7 0.32000 3.58502
TCF3 0.32000 0.33017 CCNA2 0.36000 3.58502
BAD 0.36000 0.33017 CDK6 0.36000 3.58502
FADS1 0.36000 0.33017 SPRY2 0.36000 3.58502
MAPK12 0.36000 0.33017 PICALM 0.48000 3.58502
PTP4A1 0.36000 0.33017 BRF1 0.64000 3.58502
UBC 0.36000 0.33017 CDKN1B 0.68000 3.58502
ERCC3 0.40000 0.33017 CCNE2 0.72000 3.58502
FOSL1 0.40000 0.33017 AGTPBP1 0.76000 3.58502
HSPA8 0.40000 0.33017 BIRC3 0.80000 3.58502
PICALM 0.40000 0.33017 FRAT2 0.84000 3.58502
ACBD3 0.44000 0.33017 LEF1 1.04000 3.58502
RAB5A 0.44000 0.33017 VEGF 1.08000 3.58502
RAN 0.44000 0.33017 RPP14 1.12000 3.58502
RPS6KB1 0.44000 0.33017 SMAD1 1.16000 3.58502
TGFB1 0.44000 0.33017 MAP3K9 1.20000 3.58502
CCNE1 0.48000 0.33017 RAN 1.20000 3.58502
GRB2 0.48000 0.33017 JUND 1.24000 3.58502
STAT6 0.48000 0.33017 ORC5L 1.24000 3.58502
ORC4L 0.56000 0.33017 PKIG 1.24000 3.58502
ACTB 0.60000 0.33017 BRCA1 1.28000 3.58502
MAPK14 0.68000 0.33017 EGFR 1.28000 3.58502
ORC2L 0.68000 0.33017 RAB5A 1.44000 3.86510
RHOA 0.68000 0.33017 AXIN1 1.56000 4.01971
VEGFB 0.68000 0.33017 CASP6 1.68000 4.04916
XPC 0.68000 0.33017 CDK4 1.72000 4.04916
HSPA4 0.72000 0.33017 ERCC3 1.76000 4.04916
H1FX 0.80000 0.33017 CCNB1 1.84000 4.08724
SOS1 0.80000 0.33017 MAPK3 1.96000 4.14792
SPRY2 0.80000 0.33017 BIRC2 2.08000 4.14792
AKAP1 0.84000 0.33017 CCND3 2.08000 4.14792
BRAF 0.84000 0.33017 PORCN 2.16000 4.14792
EIF2S1 0.84000 0.33017 CUL1 2.28000 4.14792
ORC5L 0.84000 0.33017 DIABLO 2.28000 4.14792
CDK4 0.88000 0.33017 CDC25C 2.36000 4.14792
DNMT3B 0.92000 0.33017 PAK1 2.44000 4.14792
TP53 0.92000 0.33017 DCK 2.52000 4.14792
JAK2 0.96000 0.33017 MAP3K5 2.60000 4.14792
RRM1 0.96000 0.33017 PRKAG2 2.64000 4.14792
ZAK 0.96000 0.33017 TP53 2.64000 4.14792
USP16 1.00000 0.33017 FAS 2.76000 4.15792
USP8 1.00000 0.33017 PTEN 2.84000 4.15792
HIF1A 1.04000 0.33127 SRC 2.84000 4.15792
APC 1.12000 0.33127 MKNK1 2.96000 4.16664
CFLAR 1.12000 0.33127 SOS1 3.04000 4.16664
MKNK1 1.12000 0.33127 TGFBR2 3.04000 4.16664
Here 2500 permutations are used and cut-off value for q is 0.5%.
Values in table are multiplied by 100.
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Table 4.2: (continued)
CNE1vsHK1 CNE1vsCNE2
Gene p.value q.value Gene p.value q.value
PSMB9 1.12000 0.33127 HIF1A 3.20000 4.20692
CDKN2A 1.16000 0.33609 UBC 3.20000 4.20692
E2F1 1.24000 0.33855 ERCC6 3.48000 4.48352
ORC6L 1.24000 0.33855 ELK4 3.68000 4.52144
PKIG 1.24000 0.33855 RHOA 3.68000 4.52144
CCNB1 1.28000 0.34287 CDKN1A 3.72000 4.52144
CDK7 1.36000 0.34870 XPC 3.92000 4.67630
NFKB2 1.36000 0.34870 TRAF2 4.04000 4.69334
CASP1 1.40000 0.34870 CDC2 4.08000 4.69334
IL1A 1.40000 0.34870 STAT6 4.20000 4.74662
BAK1 1.44000 0.35020 IL1A 4.44000 4.93134
DVL1 1.48000 0.35020 CTNNBIP1 4.52000 4.93511





















Here 2500 permutations are used and cut-off value for q is 0.5%.
Values in table are multiplied by 100.
When we compare CNE1 and CNE2 we follow the same procedure as conducted
in CNE1 and HK1. To compute the p-value and q-value we use 2500 permu-
tations. Computed q-values and expected false positives are displayed in Fig-
ure 4.2. We followed the same procedure to find differential gene expression in
CNE1 and CNE2, but even with the q-value cut-off at 0.01 we do not find any
such gene. Few genes with q-value between 0.03 and 0.04 are CCNA2, CCNE2,
CDK6, RPP14, CDKN1B, MAP3K9, PKIG, LEF1, BRF1, JUND, SPRY2, BIRC3,
FRAT2, EGFR, CDK7, SMAD1, PPP1R10, AGTPBP1, PICALM, ORC5L, BRCA1,
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VEGF and RAN. Differentially expressed genes found on some signaling pathways
are provided in Table 4.3. Differentially expressed genes are more likely to play the
key role in changing the usual pathways. We get a set of differentially expressed
genes from origin recognition complex subunit such as ORC2L, ORC4L, ORC5L
and ORC6L which are functioning the DNA replication and cell cycle (G1/S and
G2/M).
Table 4.3: Differentially expressed genes from CNE1 and HK1 on some pathways
Pathways Genes
Apoptosis Positive regulation- BAD, BAK1, CASP8, CDKN2A, CHEK2
ERCC3, MAP3K5, TGFB1, TP53
Negative regulation- BRAF, CFLAR
EGFR signaling pathway GRB2, EGFR
JNK cascade MAP3K5, ZAK
Negative regulation of cell proliferation CDKN2A, IL1A
NF-kappaB cascade CASP1, CASP8, CFLAR
Wnt receptor signaling pathway PORCN, AXIN1, DVL1, APC
JNK cascade refers stress activated protein kinase signaling pathway and EGFR signaling pathway refers
epidermal growth factor receptor signaling pathway.
To observe the expression level of genes in Table 4.3, we plot them in Figure 4.3.
As these genes are differentially expressed a gene may stimulate in one cell line but
may be suppressed in another cell line. From Figure 4.3, it is depicted that APC,
JAK2, TGFB1, TP53, ZAK, PORCN, GRB2, DVL1 and CASP1 are overexpressed
in CNE1 than in HK1. Overexpression of APC may arrest the cell cycle that causes
abnormal activity of cell cycle during one of the normal phases G1/S or G2/M.
The Wnt/beta-catenin signaling pathway is one of the main carcinogenic mecha-
nisms in human malignancies. Recently, the DVL1 gene was identified as a middle
molecule of the Wnt/beta-catenin signaling pathway. In addition, alterations of the
DVL1 gene have been reported in breast and cervical cancer (Mizutani et al., 2005).
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GRB2 is an SH2/SH3 domain-containing adaptor protein that links receptor tyro-
sine kinases to the Ras signaling pathway. The Grb2-SH2 domain binds phospho-
tyrosine sequences on activated tyrosine kinases. This causes epidermal growth fac-
tor receptor binding. An activated JAK2 phosphorylates specific tyrosine residues
on the cytoplasmic tails of the receptors creating docking sites for SH2 domain-
containing proteins such as the Signal Transducers and Activators of Transcription
(STAT) proteins. Once bound to the receptors, STATs are themselves phospho-
rylated by JAK2 on tyrosine residues. The tyrosine phosphorylated STATs then
dissociate from the receptor to form active homo- and hetero-dimer protein com-
plexes. The STAT complexes subsequently translocate into the nucleus where they
bind specific DNA sequences in gene promoter elements and modulate gene tran-
scription. Finally, normal cells started changing (Godeny and Sayeski, 2007). We
also find that one of the gene from STATs group STAT6 is differentially expressed.
It seems that this gene might have a very strong impact on cell survival and may
be suppressed by the drug use. TGFB1 causes positive regulation of cell prolifera-
tion, protein amino acid dephosphorylation and regulation of transcription. ZAK
mediates gamma radiation signaling leading to cell cycle arrest and activity of this
protein plays a role in cell cycle checkpoint regulation in cells. Checkpoint kinase
2 (CHEK2, also known as CHK2) is an evolutionarily highly conserved protein
kinase whose key function is to mediate the signal of DNA damage from ATM to
many downstream effectors including p53 and BRCA1 (Outi and Pia, 2004).
4.2.1 Summarizing the results
In this chapter we explore the differential gene expression as treatment outcomes.
Here we find differentially expressed genes by pairwise comparison of CNE1 and
HK1 as well as CNE1 and CNE2. Since the desired q-value cut-off gives differ-
entially expressed genes only from CNE1 and HK1, we compare them with the
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Figure 4.3: Differentially expressed genes on some pathways. Here solid blue,
broken red and dotted black lines represent cell line CNE1, CNE2 and HK1 re-
spectively. CDKN2A is in Figure 2.18.
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unusually expressed genes obtained from Chapter 2 (Figure 2.18-2.19). A set of
common genes identified both as outlier and differentially expressed may be highly
responded to the drug. In fact, these common genes are {CASP8, CDKN2A,
CFLAR, CHEK2, EGFR, FOSL1, FRAG1, IL1A, MAP3K5, NFKB2, SNF1LK,
SPRY2, ZAK}. We would like to refer this set of genes to biologist to discover the
biology behind these genes.
Chapter 5
Results and Discussions
Microarray time-course experiment is conducted to probe the dynamic regulation
of gene expression. In this experiments, a temporal process is measured to inves-
tigate the response of genes to treatments (for examples, drugs or environmental
conditions or cell cycle or some notion of biological regulations). Once gene ex-
pressions are available, effort is made to extract the biological meaning from the
dataset. The paradox of gene expression study is that the number of genes (may
be few hundred to few thousand) are much higher than the number of microar-
rays per gene. Moreover, for majority of the time-course experiments, number of
microarrays used are found corresponding to at most 8 time points (Ernst et al.,
2005). Even if there are few replicates at each time point, the number of microar-
rays is still very few compared to the number of genes studied. Moreover, many of
the experiments are conducted over very few time points without any replication.
Thus most of the gene expression studies suffer from the curse of dimensionality
and a dimension reduction method is applied to alleviate this problem.
We studied a dataset which comes from an in vitro experiment where a cyclin
dependent kinase (CDK) inhibitor, CYC202, is used to investigate its anti-tumor
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effect in human Nasopharyngeal Carcinoma (NPC) cells. After excluding some un-
expressed genes we have 275 genes. Since we have very few microarrays per gene
we used hierarchical clustering method by using the distance matrices obtained
from the correlation coefficients. We use three different types of distance matrices
obtained from the Pearson correlation, Spearman’s rank correlation and Kendall’s
tau coefficient. Based on silhouette width criterion we find that Pearson distance
is most suitable among the three distances considered. Thus we used Pearson dis-
tance to construct a dendogram to view the genes under different clusters. Genes
within a cluster are more likely to have similar expression pattern. From the den-
dograms we see that genes in different cell lines are grouped together in different
classes. NFKB2 is grouped with many genes in the largest cluster of CNE1 (Figure
2.5) whereas this is clustered with 8 other genes in CNE2 and that in HK1 with
28 other genes. We observe that genes NFKB2 and HSPA4 are clustered together
in CNE1 and CNE2 but not in HK1. Besides, genes IFNA1, BAX, and UBE2N
are clustered individually in HK1 but not in CNE1 and CNE2 whereas SNF1LK
is clustered alone both in CNE2 and HK1. Gene MYC is clustered with few other
genes in CNE1 but clustered only with FOSL1 and FOS in CNE2 and HK1 re-
spectively. Thus genes having similar expression in one cell line may have different
kind of expression in another cell line.
We also try principal component analysis (PCA) for dimension reduction. Heatmap
of absolute value of eigenvectors is used to observe the impact of time points on
first two components. We observe that all time points have significant impact on
components, that is, drug response is not limited to a particular time point. How-
ever, 6h for CNE1, 24h for CNE2 and 12h for HK1 are depicted to have stronger
influence on first component. If we study the combined effect of three cell lines,
12h for HK1 is found as the strongest among all time points over all cell lines, that
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is, genes may respond to the drug significantly at this time point. Further, score
plots and 90% and 95% confidence ellipsoid are used to find unusually expressed
genes. From the plot of first two components, we detect outlier genes which are
most likely to have unusual expression levels. Similarly, by using the last two com-
ponents we identify some other genes which behave differently from most of the
genes. In fact, first two components and last two components select two different
kinds of outliers. Generally, first two components select outliers which are highly
inflated in variance whereas the last two detect those which are different from most
of the objects. Some of the genes which seem to be highly expressed and obtained
from 90% and 95% confidence ellipsoid from first two components are:
CNE1 = {BRF1, CCNE2, CDKN2A,FOSL1, IFNA1,MY C, SPRY 2, UBE2N}
CNE2 = {BIRC3, CDKN2A,FOSL1, IFNA1,MAP3K5, SPRY 2}
HK1 = {CCND1, CDKN2A,EGFR,FOSL1, IFNA1, IL1B, IL1A,SPRY 2}
CNE1 ∩ CNE2 ∩HK1 = {CDKN2A,FOSL1, IFNA1, SPRY 2}
Now, we compare the above genes over different cell lines especially two extremely
responded cells CNE1 and HK1. Among unusually expressed genes in HK1, CCND1
causes G1/S transition of mitotic cell cycle, positive regulation of cyclin-dependent
protein kinase activity and protein amino acid phosphorylation. CDKN2A is higly
expressed in HK1 compared to CNE1 (Figure 2.14) and it is a highly pro-apoptotic
gene that inhibits the cyclin dependent protein kinase activity. Although IL1A and
IL1B are low anti-apoptotic the EGFR is highly pro-apoptotic. BRF1 is unusually
expressed in CNE1 but not in CNE2 and HK1. This gene initiates transcription
from RNA polymerase III promoter. Consequently, MYC causes positive regu-
lation of cell proliferation and CCNE2 participates in cell division in which cells
are divided into daughter cells. Furthermore, UBE2N conducts positive regulation
of histone modification, regulation of I-kappaB kinase/NF-kappaB cascade, NF-
kappaB transcription factor activity and ubiquitin-protein ligase activity. It seems
that the drug CYC202 controls the unusual expression of BRF1, CCNE2, MYC
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and UBE2N which are active in transcription factor activity, cell proliferation, cell
division, histone modification and NF-kappaB transcription factor activity.
To conduct the study on the time-course relationship among genes we use the
patterns based on the variation of microarrays between two time points. Rather
fixing the variation arbitrarily we estimate the parameter c ∈ (0, 1) and use the
estimated c = 0.2 to categorize the variation as up, down and very small variation
as 1, -1 and 0 respectively. Then the time-course relationship among the genes are
studied (Table 3.2). Thereafter, we conduct the model based profile analysis to find
genes for which expression levels are more likely to be similar. We only find some
genes common to both CNE2 and HK1 (Subsection 4.2.6) which is also supported
by pattern-profile analysis as we get more common genes between CNE2 and HK1
for c = 0.2 (Figure 3.2). Let us consider genes BRF1 and CCNE2 from Table 3.2
where the patterns for both genes in CNE1 are same, that is, they are coregulated
in CNE1. Although in CNE2 and HK1 both genes initially seem to down regulate
a little bit, however, they are upregulated after third time period. Similarly, we
can compare ADM (-111-11) and CFLAR (1-1-111) from CNE1. If we multiply
the pattern of ADM by -1 we get the similarity of pattern of CFLAR upto the
fifth time period, that is, they may have some reverse regulatory relationship. In
other words, when one is activating another is inhibiting. Similarly, CFLAR and
CHEK2 have same expression pattern both in CNE2 and HK1. Although in CNE1
there are differences in 0 positions of CHEK2, however, this does not imply that
the expression level is constant rather varies with a very limited direction. Thus
CFLAR and CHEK2 seem to be coregulated.
Genes which are differentially expressed over some biological conditions are sup-
posed to be biologically interesting. We used the DeCook et al. (2006) procedure to
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detect the differentially expressed genes. To compute the expected false positives
and q-value cut-off for this significance analysis we use the methods of Storey and
Tibshirani (2003) followed by 2500 permutations. By using the q-value cut-off at
0.005 we get 80 differentially expressed genes (Table 4.2). If we compare the genes
for GO categories then we find a very few genes as the number of genes under study
was only 380. Genes BRAF and CFLAR are found differentially expressed which
cause negative regulation to apoptosis. However, many genes are found to have
positive regulation to apoptosis such as BAD, BAK1, CASP8, CDKN2A, CHEK2,
ERCC3, MAP3K5, TGFB1 and TP53. Only two genes MAP3K5 and ZAK from
stress activated protein kinase signaling pathway are significantly changes in HK1
compared to CNE1. A very influential gene JAK2 in the JAK-STAT signaling
pathway is also changes significantly in HK1. Besides, PORCN, AXIN1, DVL1
and APC are also differentially expressed.
Differentially expressed genes on a certain pathway breaks the usual relationship
and may cause cell proliferation or cell death. In Chapter 4, we explored that
APC, JAK2, TGFB1, TP53, ZAK, PORCN, GRB2, DVL1 and CASP1 are over-
expressed in CNE1 than in HK1. As discussed in Chapter 4, GRB2, JAK2 and
ZAK are anticipated as prominent stimulating genes in CNE1 and thus causing
resistance to the treatment. On the other hand, these genes are suppressed in
HK1. Moreover, genes with positive regulation of apoptosis and negative regu-
lation to cell proliferation have strong impact on cancer recovery. However, this
initiation can be happened in many ways through many pathways. Some selected
genes in Table 4.3 are supposed to have greater impact on cell death as a result
of drug CYC202 and so we observe improvement of HK1 cell but least improve-
ment of CNE2. Last but not least, we may say that there are more ways the
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cell death and negative regulation of cell proliferation may happen and we keep
this for biologist. We found some common genes identified both as outlier and
differentially expressed are CASP8, CDKN2A, CFLAR, CHEK2, EGFR, FOSL1,
FRAG1, IL1A, MAP3K5, NFKB2, SNF1LK, SPRY2, ZAK. Constrained by our
knowledge in molecular biology, we would like to refer this set of genes to biologist
to discover the biology behind these genes.
5.1 Conclusion
In this thesis, we review the problem of analyzing time-course gene expression data.
Using the nasopharyngeal carcinoma gene expression data we study the choice of
distance measure to cluster similar gene expressions. Some unusually expressed
genes were identified from the outlier detection by principle component analysis
and their time-course regulation were studied. Motivated by the objectives of our
study we identified differentially expressed genes and outliers. We would like to
refer a set of genes identified both as differentially expressed and outlier to biologist
to discover the biology behind these genes. Stimulation and suppression of those
hypothesized genes may play a significant role in nasopharyngeal cancer recovery
under the treatment with CYC202. Last but not least, expressions of a few genes
were studied and many genes may interplay the same role in cancer recovery, so
extensive in vitro and in vivo experiments over more genes may be conducted with
some replication to hypothesize some key genes to be altered during treatment.
5.2 Further research
We use the in vitro dataset to find the time-course relationship and differentially
expressed genes. But to conduct the study on how the patients recover and in what
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context particular gene changes, we can borrow some idea from the in vivo experi-
ments. In future, drug deciphering pathways can be constructed for drug tracking
and treatment setup to change particular genes by combining the in vivo results
with the obtained time-course relationship and differentially expressed genes.
Appendix A
Some useful R commands
Through out the thesis we used R programming language for computation. Some
of the R commands used during computation are given below.

















# Compute eigenvectors and scores in principal component analysis









add=TRUE, cex=0, col=1, lwd=0.75)
data.ellipse(pc.scores[,1],pc.scores[,2], levels=0.9, lty=2,
add=TRUE, cex=0, col=1, lwd=0.7)
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